Emergencies end eventually: How to better analyze human rights restrictions sparked by the COVID-19 pandemic under the international covenant on civil and …
E Richardson, C Devine - Mich. J. Int'l L., 2020 - HeinOnline
On March 11, 2020, the World Health Organization declared the novel coronavirus (" COVID-19")
a pandemic, but even before the official declara-tion, UN member states began …
a pandemic, but even before the official declara-tion, UN member states began …
Algorithmic Trading
P Bergan, C Devine - The Journal of Trading (Retired), 2005 - pm-research.com
In this article, Bergan and Devine consider the advantages and disadvantages that algorithmic
trading offers the investment industry. The authors outline the evolution of the market, …
trading offers the investment industry. The authors outline the evolution of the market, …
[PDF][PDF] Sojourner Truth
C Devine, B Morrison, J Olewnik, S Temme - 2002 - conservancy.umn.edu
Her third master, John Dumont, forced her to marry another slave by the name of Thomas.
They had five children, most of whom were sold into slavery. As soon as Isabella could, she …
They had five children, most of whom were sold into slavery. As soon as Isabella could, she …
[HTML][HTML] The emergence of Japanese encephalitis in Australia and the implications for a vaccination strategy
Japanese encephalitis (JE) is the leading cause of viral encephalitis in Asia. Until 2022,
only six locally transmitted human JE cases had been reported in Australia; five in northern …
only six locally transmitted human JE cases had been reported in Australia; five in northern …
Immunogenicity of a single fractional intradermal dose of Japanese encephalitis live attenuated chimeric vaccine
Background Japanese encephalitis (JE) is endemic in Asia and the western Pacific. Vaccination
is recommended for travellers to endemic regions, but the high cost of the vaccine is a …
is recommended for travellers to endemic regions, but the high cost of the vaccine is a …
Investigational screening for Babesia microti in a large repository of blood donor samples from nonendemic and endemic areas of the United States
…, DE Krysztof, RL Townsend, GA Foster, P Devine… - …, 2014 - Wiley Online Library
Background B abesia microti, a transfusion‐transmissible intraerythrocytic parasite, is
increasing in frequency in the U nited S tates with no available FDA ‐licensed donor screening …
increasing in frequency in the U nited S tates with no available FDA ‐licensed donor screening …
[CITATION][C] The value of postprofessional education
…, L Nelson, MT Bowman, C Devine… - … American Journal of …, 2000 - research.aota.org
(AJOT, September/October 1999, 454-458). We are currently in the process of completing
our master’s degree in occupational therapy via San Jose State University’s on line program. …
our master’s degree in occupational therapy via San Jose State University’s on line program. …
… order): Gabriela Alvarez-Avila, David L. Attanasio, Zeïneb Bouraoui, Damien Charlotin, Kyongwha Chung, Berk Demirkol, Colleen Devine, Alexander Ferguson, Jaime …
MG Rebolledo, O Hailes, CH Durán, Z Kady, TF Lane… - cambridge.org
Acknowledgements | ICSID Reports | Cambridge Core Skip to main content Accessibility help
We use cookies to distinguish you from other users and to provide you with a better experience …
We use cookies to distinguish you from other users and to provide you with a better experience …
[HTML][HTML] Outcomes after reinfusion of CD19-specific chimeric antigen receptor (CAR)-modified T cells in children and young adults with relapsed/refractory B-cell acute …
RM Myers, K Devine, Y Li, S Lawrence, AB Leahy… - Blood, 2021 - Elsevier
Background: CAR-modified T cells targeting CD19 have produced remarkable responses in
relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL); however, relapse …
relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL); however, relapse …
[HTML][HTML] Complete versus incomplete hematologic recovery after CAR T cell therapy: implications for relapse free survival and overall survival in pediatric and young …
Background: Anti-CD19 Chimeric Antigen Receptor (CAR) T cell therapy has emerged as a
mainstay in the treatment of patients with relapsed/refractory (r/r) B-cell acute lymphoblastic …
mainstay in the treatment of patients with relapsed/refractory (r/r) B-cell acute lymphoblastic …